3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Prostatic Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Locally Advanced (Inoperable) or Metastatic Breast Cancer
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Moderate Hepatic Impairment
1
Meningioma
1
Healthy Participants
1
Glioma
1
Esophageal Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chondrosarcoma
1
Carcinosarcoma
1
Interventions
Vincristine
7
Cyclophosphamide
7
Methotrexate
6
Dexamethasone
6
Cytarabine
6
merphos
5
Mercaptopurine
5
Doxorubicin
5
pegaspargase
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
blinatumomab
4
azathiopurine
4
auricularum
4
Prednisone
4
Leucovorin
4
Inotuzumab Ozogamicin
4
Calcium Dobesilate
4
prednylidene
3
deltacortene
3
Thioguanine
3
Specimen Handling
3
N,N-dicyclohexyl-isoborneol-10-sulfonamide
3
Methylprednisolone
3
Asparaginase
3
calaspargase pegol
2
asparaginase erwinia chrysanthemi recombinant
2
Spinal Puncture
2
Rituximab
2
Radiotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
capivasertib
×
90 days
×
Clear all
No trials found.